Health TrialsbyHealthPanel

A Setting Focus Overdose Prevention Intervention

ConditionsHIV InfectionsHCVDrug Overdose
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorJohns Hopkins Bloomberg School of Public Health

About this trial

A pilot injection-setting targeted peer-driven intervention to reduce HIV and hepatitis C virus transmission and overdose risk behaviors among people who inject drugs (PWID).

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Current drug user (opioid use in the prior two weeks)

Disqualifiers

Any mental or physical health impairment that impedes ability to participate

Trial design

Design model

Parallel

Treatments tested in this trial

  • HIV, HCV and overdose prevention

    Behavioral

    HIV, HCV and overdose prevention

Treatment groups

285 Participants
are divided into 2 treatment groups
Group A: ExperimentalExperimental treatment 1 intervention
Group B: comparisonActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Overdose prevention

Frequency of carrying naloxone

Time frame
6 months
2

HIV/HCV prevention

Frequency of using used cookers

Time frame
6 months

Secondary outcomes

1

Overdose behaviors

Frequency of testing drugs before using

Time frame
6 months
2

Overdose behaviors 2

Frequency of talking about overdose prevention

Time frame
6 months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Johns Hopkins Bloomberg School of Public Health

Lead sponsor

National Institute on Drug Abuse (NIDA)

Collaborator

Source ClinicalTrials.gov
Apply now